Getting started

GLP-1 for men: what is different, what is the same, and what providers cater to men

GLP-1 marketing skews heavily female, but men respond to the drugs equally well — sometimes better. Here is what differs (testosterone, muscle, cardiovascular angle) and what stays the same (eligibility, dosing, side effects).

By Priya Sharma, NPNurse practitioner · GLP-1 specialty clinic6 min read

Medically reviewed by Jane Novak, MD, MPH, Endocrinology · Internal medicineUpdated May 24, 2026

Eligibility is identical

FDA approved GLP-1s for chronic weight management apply to adults — male or female — with BMI ≥30, or BMI ≥27 with at least one weight-related condition. No sex-specific criteria.

Insurance coverage is also sex-neutral. The qualifying conditions matter (hypertension, sleep apnea, dyslipidemia, type 2 diabetes, CV disease) — and men are typically over-represented in several of these, which can make insurance approval easier.

How men respond differently

Absolute pounds lost: men typically lose more (larger starting weight, more muscle mass = higher BMR). Percentage loss: similar to women — semaglutide ~12-15%, tirzepatide ~18-22%.

Visceral fat: men carry more abdominal visceral fat. GLP-1s preferentially target this, so cardiometabolic markers (blood pressure, A1C, lipids, liver enzymes) improve disproportionately in men.

Strength loss: men lose absolute muscle mass faster on a GLP-1 because they had more to lose. Resistance training + 1.0 g/lb protein target is non-negotiable.

GLP-1 and testosterone: the low-T loop

Obesity drives low testosterone in three ways: aromatase activity in adipose tissue converts T to estrogen, leptin resistance disrupts HPG axis, and visceral fat creates inflammatory milieu. Many men with obesity have functional hypogonadism.

Weight loss on a GLP-1 reverses this loop in roughly 60-70% of cases — testosterone rises back to normal range without TRT. For men currently on TRT, dose reduction or discontinuation may become appropriate after meaningful weight loss.

Discuss with your prescriber before stopping or adjusting TRT independently — the rise is gradual and requires monitoring.

Telehealth providers that cater to men

Hims (Hims & Hers male-targeted brand): launched oral Wegovy program at $149/mo in March 2026. Heavy male marketing, full GLP-1 menu including Zepbound.

Ro: gender-neutral but strong male brand presence; full GLP-1 formulary including Foundayo.

Push Health: doctor-to-doctor referral model; popular with men comfortable navigating prior auth.

Frequently asked questions

Does Ozempic work for men?
Yes — equally effective as in women in percentage terms, often more in absolute pounds. Same eligibility, same dosing, same side effects.
Can men get Wegovy or Zepbound?
Yes, no sex-specific restrictions. Eligibility: BMI ≥30, or BMI ≥27 + at least one weight-related condition.
Does Ozempic increase testosterone?
Indirectly. Weight loss in men with obesity often reverses functional hypogonadism, raising endogenous testosterone back to normal range in 60-70% of cases. Direct effect on testosterone production has not been shown.
Should I stop TRT if I start a GLP-1?
Discuss with your prescriber. Many men can reduce or stop TRT after meaningful weight loss, but the rise in endogenous T is gradual — monitor lab values before adjusting.
Which telehealth provider is best for men on GLP-1?
Hims has the most male-targeted GLP-1 program (including the lowest-cost oral Wegovy at $149/mo). Ro has the broadest formulary. Both are strong choices.

Disclosure: Glpverdict is affiliate-funded but editorially independent. Some links above are sponsored — we may earn a commission if you sign up with a partner provider. This does not affect our editorial rankings or medical review.